Donidalorsen sodium
Based on 1 Customer Validation
Donidalorsen (ISIS-721744; IONIS-PKK-LRX) sodium is an antisense oligonucleotide targeting prekallikrein (PKK). Donidalorsen sodium inhibits kallikrein activity and reduces the production of Bradykinin (HY-P0206) by specifically binding to and degrading PKK mRNA in the liver. Donidalorsen sodium can be used in the research of hereditary angioedema.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 95.90%
- No. CAS: 2304701-45-7
- Fòrmula: C296H435N83Na20O151P20S15
- Peso molecular:8672.6 (free acid)
-
Almacenamiento:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Actividad biológica
Descripciòn
In Vitro
Donidalorsen sodium binds selectively to hepatic prekallikrein mRNA, mediates its degradation via ribonuclease H1, reduces hepatic prekallikrein production, reduces plasma prekallikrein concentrations, reduces plasma D-dimer concentrations, inhibits prekallikrein protein production, and reduces hereditary angioedema attack frequency[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
No. CAS 2304701-45-7
-
Appearance Solid
-
Peso molecular 8672.6 (free acid)
-
Fòrmula C296H435N83Na20O151P20S15
-
Color White to off-white
-
SMILES
[Donidalorsen (sodium)]
-
Synonyms
ISIS-721744; IONIS-PKK-LRX
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Protocolo
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
Pureza y Documentación
-
Ficha de datos (265 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instrucciones de manejo (2242 KB)
Referencias
[1]. Petersen RS, et al. A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema. Allergy. 2024;79(3):724-734. [Content Brief]
[2]. Diep JK, et al. Population Pharmacokinetic/Pharmacodynamic Modeling of Donidalorsen, an Antisense Oligonucleotide in Development for Prophylaxis of Hereditary Angioedema. CPT Pharmacometrics Syst Pharmacol. 2026;15(2):e70206. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Donidalorsen
- 2304701-45-7
- ISIS-721744
- IONIS-PKK-LRX
- ISIS721744
- ISIS 721744
- Kallikrein
- hepatocyte asialoglycoprotein receptors
- prekallikrein protein
- triantennary N-acetylgalactosamine
- prekallikrein mRNA
- plasma prekallikrein
- hereditary angioedema
- ribonuclease H1
- bradykinin
- exon 9
- HAE type I or II
- Inhibitor
- inhibitor
- inhibit